Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk

Ramin Tehranchi1, Rosangela Invernizzi, Alf Grandien

  • 1Department of Medicine, Division of Hematology, Karolinska Institutet, Karolinska University Hospital Huddinge, S-141 86 Stockholm, Sweden. ramin.tehranchi@medhs.ki.se

Blood
|March 10, 2005
PubMed

Insights

Early erythroblast mitochondrial dysfunction, marked by cytochrome c release and mitochondrial ferritin (MtF) accumulation, is a key feature in myelodysplastic syndromes (MDS), particularly refractory anemia with ringed sideroblasts (RARS). This occurs early in erythroid differentiation, indicating a block in maturation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Biology

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective erythropoiesis and peripheral blood cytopenias.
  • Refractory anemia (RA) and RA with ringed sideroblasts (RARS) are subtypes of MDS.
  • Mitochondrial dysfunction and aberrant protein accumulation are implicated in MDS pathogenesis.

Purpose of the Study:

  • To investigate the role of mitochondrial cytochrome c release and mitochondrial ferritin (MtF) expression in early erythroid differentiation in MDS.
  • To analyze gene expression patterns related to apoptosis and erythroid differentiation in MDS patients.
  • To identify potential molecular mechanisms underlying the block in erythroid maturation in MDS.

Main Methods:

  • Analysis of cytochrome c release and MtF expression in bone marrow cells from MDS patients (RA and RARS) and healthy controls.
  • In vitro culture of erythroid cells to study differentiation.
  • Quantitative analysis of mRNA expression for cytochrome c, apoptotic genes (Bid, Bax), and erythroid transcription factors (GATA-1).

Main Results:

  • Early erythroblasts in RA and RARS exhibit constitutive mitochondrial release of cytochrome c.
  • Aberrant MtF accumulation is observed in mature erythroblasts in RARS, but not RA.
  • MtF expression is detected at an early CD34+ stage in RARS erythroblasts, preceding morphologic differentiation.
  • MDS patients show overexpression of mRNA for cytochrome c, Bid, and Bax.
  • Genes involved in erythroid differentiation are dysregulated in MDS cells.
  • GATA-1 expression remains low in MDS cultures, indicating a transcriptional block in erythroid maturation.

Conclusions:

  • Aberrant MtF expression in RARS erythroblasts occurs very early in erythroid differentiation.
  • Early mitochondrial dysfunction and altered gene expression, including upregulation of apoptotic genes and downregulation of GATA-1, contribute to ineffective erythropoiesis in MDS.
  • These findings highlight a block in erythroid maturation at the transcriptional level in MDS.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...